Ontario’s COVID-19 Genomics Rapid Response Coalition
To accelerate the genomic characterization and surveillance of SARS-CoV-2 in Ontario and to help expedite patient genome sequencing through a coordinated approach bringing together all of the province’s genomics resources and capacity to enable timely and comprehensive genomic analysis.
Standardized Sequencing Methodologies
Data Management & Sharing
The ON-CoV Coalition is designed to provide for method standardization and coordination of:
Collecting Patient Samples and Metadata
Data Curation and Management
This work will expedite real-time testing and reporting to inform public health and public policy, help manage and overcome the ongoing COVID-19 crisis and ensure scalability for Ontario’s future pandemics preparedness.
Genomic technologies are the foundation for the solutions necessary to combat the ongoing COVID-19
pandemic. Ontario’s world-leading expertise in genomics, bioinformatics, genomics epidemiology, and artificial intelligence, can expedite Ontario’s response to COVID-19.
The results reported by the Coalition will inform vaccine and therapeutic development.
Why Ontario Genomics?
Over the past 20 years, Ontario Genomics, together with the Ontario Government, Genome Canada, and academic, clinical and industry partners, has built a world-leading genomics ecosystem in Ontario with over $2.7B in funding leveraged for research, translation and the establishment of genomic technology platforms.
Ontario Genomics is well-positioned to provide and promote:
ONCoV Genomics Coalition Steering Committee
Dr. Herveen Sachdeva, Toronto Public Health
Dr. Sarah Wootton, University of Guelph
ONCoV Genomics Coalition Members
University of Toronto
Sunnybrook Health Sciences / University of Toronto
Health Sciences North
Dalla Lana School of Public Health, University of Toronto
Public Health Ontario
Sinai Health Systems
Hospital for Sick Children / University of Toronto
TCAG / CGEn
Kingston Health Sciences Centre / Queen’s University
Ontario Institute for Cancer Research
Unity Health Toronto / University of Toronto
Peter Munk Cardiac Centre, UHN / University of Toronto
University of Guelph
We are proactively working with the research community, partner genome centres, and governments to accelerate the genomic characterization and surveillance of SARS-CoV-2 in Ontario. Learn more and stay up-to-date about our COVID-19 programs and important resources.
Canada’s BioRevolution 2020 Webinar Series – “Editing our Economic Future: The Power of CRISPR”
September 28, 2000 - 12pm
“Editing our Economic Future: The Power of CRISPR” will showcase a conversation between Gairdner Foundation laureates and leading Canadian researchers on using the opportunities and applications of gene editing, specifically by using CRISPR/Cas9, to transform multiple sectors.
September 15, 2020
Government of Canada: Policy Statement on Research Security and COVID-19
September 14, 2020
The Government of Canada is encouraging all members of the research ecosystem to be aware of the potential risks to their work and asking them to take appropriate measures to protect their knowledge creation and innovations, all while maintaining a strong commitment to Open Science and support for a global research response to the COVID-19 pandemic.
Predicting the recombination potential of severe acute respiratory syndrome coronavirus 2 and Middle East respiratory syndrome coronavirus
Key members of the ONCoV Genomics Coalition, Samira Mubareka and Andrew McArthur conducted a collaborative study analyzing and predicting the recombination potential of SARS-CoV-2 and the Middle East respiratory syndrome coronavirus.
September 9, 2020